Translate Bio to Participate in Upcoming Investor Conferences
- SVB Leerink CybeRx Series: Rare Diseases & Genetic Medicines,
October 1, 2020
- Guggenheim 1st Annual Vaccines and Infectious Diseases Day,
October 5-6, 2020
- Chardan Virtual 4th Annual
Genetic Medicines Conference, October 5-6, 2020 Ronald Renaud, chief executive officer, will participate in a fireside chat at the Chardan Virtual 4th Annual Genetic Medicines Conferenceon Tuesday, October 6, 2020, at 1:00 p.m. ET.
- A live webcast of the session will be accessible through the “Events and Presentations” page of the Company's website at investors.translate.bio. A replay of the webcast will be archived on the Translate Bio’s website for 30 days following the presentation.
Source: Translate Bio, Inc.